Abstract
Glioblastomas are the most aggressive primary brain tumor. Despite treatment with surgery, radiation and chemotherapy, these tumors remain uncurable and few significant increases in survival have been observed over the last half-century. We recently employed a combined theoretical and experimental approach to predict the effectiveness of radiation administration schedules, identifying two schedules that led to superior survival in a mouse model of the disease (Leder et al., Cell 156(3):603–616, 2014). Here we extended this approach to consider fractionated schedules to best minimize toxicity arising in early- and late-responding tissues. To this end, we decomposed the problem into two separate solvable optimization tasks: (i) optimization of the amount of radiation per dose, and (ii) optimization of the amount of time that passes between radiation doses. To ensure clinical applicability, we then considered the impact of clinical operating hours by incorporating time constraints consistent with operational schedules of the radiology clinic. We found that there was no significant loss incurred by restricting dosage to an 8:00 a.m. to 5:00 p.m. window. Our flexible approach is also applicable to other tumor types treated with radiotherapy.
Similar content being viewed by others
References
Bertuzzi A, Bruni C, Papa F, Sinisgalli C (2013) Optimal solution for a cancer radiotherapy problem. J Math Biol 66(1–2):311–349
Bleau A, Hambardzumyan D, Ozawa T, Fomchenko E, Huse J, Brennan C, Holland E (2009) PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 4(3):226–235
Brennan C, Momota H, Hambardzumyan D, Ozawa T, Tandon A, Pedraza A, Holland E (2009) Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS One 4(11):e7752
Brenner D, Hlatky L, Hahnfeldt P, Huang Y, Sachs R (1998) The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships. Radiat Res 150(1):83–91
Brenner D (2008) The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 18:234–239
Charles N, Ozawa T, Squatrito M, Bleau A, Brennan C, Hambardzumyan D, Holland E (2010) Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell 6(2):141–152
Chen J, Li Y, Yu T, McKay R, Burns D, Kernie S, Parada L (2012) A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488(7412):522–526
Dale R, Jones B (2007) Radiobiological modelling in radiation oncology. Lippincott Williams & Wilkins, Philadelphia
Dionysiou D, Stamatakos G, Uzunoglu N, Nikita K, Marioli A (2004) A four-dimensional simulation model of tumor response to radiotherapy in vivo: parametric validation considering radiosensitivity, genetic profile and fractionation. J Theor Biol 230(1):1–20
Fowler J (2010) 21 years of effective dose. Br J Radiol 83:554–568
Fowler J (1989) The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62(740):679–694
Hall E, Giaccia A (2006) Radiobiology for the radiologist. Lippincott Williams & Wilkins, Philadelphia
Harpold H, Alvord E, Swanson K (2007) The evolution of mathematical modeling of glioma proliferation and invasion. J Neuropathol Exp Neurol 66(1):1–9
Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2013) SEER cancer statistics review, 1975–2010. National Cancer Institute, Bethesda
Laperriere N, Zuraw L, Cairncross G, Cancer Care Ontario Practice Guidelines Initiative Neuro-Oncology Disease Site Group (2002) Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol 64(3):259–273
Leder K, Pitter K, LaPlant Q, Hambardzumyan D, Ross B, Chan T, Holland E, Michor F (2014) Mathematical modeling of PDGF-driven glioblastoma reveals optimized radiation dosing schedules. Cell 156(3):603–616
Lu W, Chen M, Chen Q, Ruchala K, Olivera G (2008) Adaptive fractionation therapy: I. Basic concept and strategy. Phys Med Biol 53(19):5495
Mizuta M, Takao S, Date H, Kishimoto N, Sutherland L, Onimaru R, Shirato H (2012) A mathematical study to select fractionation regimen based on physical dose distribution and the linear-quadratic model. Int J Radiat Oncol Biol Phys 84(3):829–833
Orlandi E, Palazzi M, Pignoli E, Fallai C, Giostra A, Olmi P (2010) Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: a review. Crit Rev Oncol Hematol 73(2):111–125
Pajonk F, Vlashi E, McBride W (2010) Radiation resistance of cancer stem cells: the 4 R’s of radiobiology revisited. Stem Cells 28(4):639–648
Phillips H, Kharbanda S, Chen R, Forrest W, Soriano R, Wu T, Misra A, Nigro J, Colman H, Soroceanu L et al (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9(3):157–173
Phillips H, Kharbanda S, Chen R, Forrest W, Soriano R, Wu T, Aldape K (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9(3):157–173
Pierre D (1969) Optimization theory with applications. Wiley, New York
Rich J (2007) Cancer stem cells in radiation resistance. Cancer Res 67(19):8980–8984
Rockne R, Alvord E, Rockhill J, Swanson K (2009) A mathematical model for brain tumor response to radiation therapy. J Math Biol 58(4–5):561–578
Stamatakos G, Antipas V, Uzunoglu N, Dale R (2006) A four-dimensional computer simulation model of the in vivo response to radiotherapy of glioblastoma multiforme: studies on the effect of clonogenic cell density. Br J Radiol 79:389–400
Unkelbach J, Craft D, Salari E, Ramakrishnan J, Bortfeld T (2013) The dependence of optimal fractionation schemes on the spatial dose distribution. Phys Med Biol 58(1):159
Verhaak R, Hoadley K, Purdom E, Wang V, Qi Y, Wilkerson M, Cancer Genome Atlas Research Network (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17(1):98–110
Withers R (1975) The four R’s of radiotherapy. Adv Radiat Biol 5(3):241–271
Yang Y, Xing L (2005) Optimization of radiotherapy dose-time fractionation with consideration of tumor specific biology. Med Phys 32(12):3666–3677
Acknowledgments
HB is partially supported by NSF Grants CMMI-1362236. KL is partially supported by NSF Grants DMS-1224362 and CMMI-1362236. FM is partially supported by the Grant NIH U54CA143798. E.H is supported by NIH grants U54 CA143798 and U54CA163167-01. We would like to thank an anonymous referee for their helpful comments.
Author information
Authors and Affiliations
Corresponding author
Appendix
Appendix
1.1 Technical lemma
We prove here a technical lemma, which is quite standard but we provide a proof for completeness.
Lemma 3
For \(a>0\) and f a bounded function on [0, a] and continuous at 0,
Proof
First note that
and it thus suffices to establish that
For \(\nu >0\), define \(\ell (\nu )=\log (\nu )/\nu \) and then consider the decomposition
Both terms on the final line in the previous display then go to 0 as \(\nu \rightarrow \infty \) due to our assumptions on the function f. \(\square \)
Rights and permissions
About this article
Cite this article
Badri, H., Pitter, K., Holland, E.C. et al. Optimization of radiation dosing schedules for proneural glioblastoma. J. Math. Biol. 72, 1301–1336 (2016). https://doi.org/10.1007/s00285-015-0908-x
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00285-015-0908-x